You are viewing an incomplete version of our website. Please click to reload the website as full version.

p63 antibody (Tumor Protein P63)

Details for Product anti-TP63 Antibody No. ABIN93814, Supplier: Login to see
Antigen
  • TP63
  • tp63
  • TP73L
  • AI528772
  • CCT
  • Cct1
  • Ccta
  • TRic
  • Tcp-1
  • Tp63
  • c-cpn
  • p63
  • AI462811
  • Ket
  • P51/P63
  • P63
  • P73l
  • Trp53rp1
  • AIS
  • B(p51A)
  • B(p51B)
  • EEC3
  • KET
  • LMS
  • NBP
  • OFC8
  • RHS
  • SHFM4
  • TP53CP
  • TP53L
  • p40
  • p51
  • p53CP
  • p73H
  • p73L
  • Tp73l
  • Trp63
  • DNp63
  • id:ibd3516
  • tp73l
  • wu:fc89f04
  • wu:fk85h07
  • wu:fk88b02
  • Xp63
  • ket
  • np63
  • tp73l-A
  • trp63
  • TRP63
Reactivity
Human, Mouse (Murine), Rat (Rattus)
68
17
17
2
2
1
Host
Mouse
37
29
2
Clonality (Clone)
Monoclonal ()
Conjugate
This p63 antibody is un-conjugated
1
1
1
1
1
1
Application
Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
47
40
16
12
3
3
3
1
1
1
Supplier
Login to see
Supplier Product No.
Login to see
Request

Showcase your results, aid the scientific community, and receive a full refund.

Contribute a validation

Learn more

Immunogen Recombinant p63 Protein (AA 1-205) N-terminal part of deltaNp63
Clone 4A4
Isotype IgG2a
Specificity P63 (6 Isotypes)
Alternative Name p63 Protein (TP63 Antibody Abstract)
Research Area Cancer, Signaling, Apoptosis/Necrosis
Pathways
Application Notes IHC (C,P) , Antigen unmasking after formaldehyde fixation by heat treatment in EDTA solution pH 9 . neat Positive Control: Normal prostate tissue or skin (epidermis)
Restrictions For Research Use only
Format Liquid
Buffer stabilizing phosphate buffer pH 7.3. Contains 0.09 % sodium azide. The volume is sufficient for at least 100 immunohistochemical tests (100 ul working solution / test)
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage 4 °C
Background publications Pelosi G, Pasini F, Olsen Stenholm C et al.: "p63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas?" in: J Pathol, Vol. 198, Issue 1, pp. 100-9, 2002 (PubMed).

Signoretti, Waltregny, Dilks et al.: "p63 is a prostate basal cell marker and is required for prostate development." in: The American journal of pathology, Vol. 157, Issue 6, pp. 1769-75, 2000 (PubMed).

Celli J, Duijf P, Hamel BC et al.: "Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome." in: Cell, Vol. 99, Issue 2, pp. 143-53, 1999 (PubMed).

Yang, Kaghad, Wang et al.: "p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities." in: Molecular cell, Vol. 2, Issue 3, pp. 305-16, 1998 (PubMed).